Clinical Trials Browser

Mastocytosis, Systemic × 30 days × Clear all

NCT04910685 2026-04-06

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Phase 2/3 Recruiting

Mastocytosis, Systemic

NCT03401060 2026-03-31

DenosuMast

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic